Edarbyclor Tablet
Product Images NDC 60631-412

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Edarbyclor (NDC 60631-412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1.a (Edarbyclor 01)

This appears to be a medical prescription or record, specifying a medication called Edarbyclor 40/25 mg, containing Azilsartan medoxomil 80 mg and Chlorthalidone 25 mg. The document also provides a range of baseline Systolic BP (blood pressure) values from 140 to 190 mmHg, and mentions that the medication is indicated for patients with a Systolic BP below 140 mmHg.*

FDA Label Image

Figure 1.b (Edarbyclor 02)

This is a chart of different blood pressure readings with medication recommendations. The goal blood pressure is below 130 mmHg for systolic blood pressure. The medications listed are chlorthalidone 25, azilsartan medoxomil 80 mg, and Edarbyclor 40/25 mg. The chart also includes a baseline systolic BP reading range from 155 to 175 mmHg.*

FDA Label Image

Figure 1.c (Edarbyclor 03)

This appears to be a graph showcasing blood pressure readings for different drugs and dosages. The baseline diastolic blood pressure (DBP) is plotted on the x-axis with a scale ranging from 90-115 mmHg. The medications Azilsartan medoxomil (40 and 80 mg) and Chlorthalidone 25 mg as well as a combination drug Edarbyclor (40/25 mg) are listed on the y-axis. The percentage of subjects whose DBP was less than 90 mmHg is listed at 9% for each drug.*

FDA Label Image

Figure 1.d (Edarbyclor 04)

The text seems to be a mix of blood pressure readings and medication names. It is not possible to generate a useful description with this text.*

FDA Label Image

Chemical Structure (Edarbyclor 05)

FDA Label Image

Chemical Structure (Edarbyclor 06)

FDA Label Image

Figure 2 (Edarbyclor 07)

This is a population description table that includes information on age, gender, race, renal impairment, hepatic impairment, pediatric patients, percent change, fold change and 90% confidence interval. The table lists different values and recommendations for various subgroups based on their characteristics. The recommendation for all subgroups is no dose adjustment except for the one with no experience.*

FDA Label Image

Figure 3 (Edarbyclor 08)

FDA Label Image

Principal Display Panel (40 mg/12.5 mg Tablet Bottle Label)

This is a bottle of Edarbyclor containing 30 tablets. The tablets contain Azilsartan Medoxomil and Chlorthalidone and come in an original container. Each tablet contains 12.5 mg chlorthalidone. It is recommended not to use if a tamper-evident seal is broken or missing and not to repackage or remove the desiccant canisters. The typical dosage can be found in the package insert and it should be stored at 25°C (77°F), with excursions to 16-30°C (50-86°F). The tablets are Rx Only. The bottle should be kept tightly closed, protecting from moisture and light. The address of the manufacturer is in Atlanta, GA and Osaka, Japan.*

FDA Label Image

Principal Display Panel (40 mg/25 mg Tablet Bottle Label)

This is a description of a medication with the NDC code 60631-425-30, which is a container with 30 tablets of Edarbyclor. This medication contains 40mg of Azilsartan Medoxomil and 25mg of Chlorthalidone per tablet. The container has instructions not to accept it if the tamper-evident seal is missing or broken, also not to repackage, or remove desiccant canisters. The usual dosage is provided in the package insert. It should be stored at a temperature of 25°C, with allowable excursions to 15-30°C, and protected from moisture and light. This medication is manufactured by Mandfactrd in Osaka, Japan, and is a prescription drug.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.